| Autor: |
Scarpato E; Department of Translational Medical Sciences - Section of Paediatrics, University of Naples 'Federico II', Via S. Pansini 5, 80131, Naples, Italy., Strisciuglio C; Department of Women, Child and Specialist Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy., Martinelli M; Department of Translational Medical Sciences - Section of Paediatrics, University of Naples 'Federico II', Via S. Pansini 5, 80131, Naples, Italy., Russo M; Department of Translational Medical Sciences - Section of Paediatrics, University of Naples 'Federico II', Via S. Pansini 5, 80131, Naples, Italy., Cenni S; Department of Translational Medical Sciences - Section of Paediatrics, University of Naples 'Federico II', Via S. Pansini 5, 80131, Naples, Italy., Casertano M; Department of Women, Child and Specialist Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy., Serra MR; Department of Translational Medical Sciences - Section of Paediatrics, University of Naples 'Federico II', Via S. Pansini 5, 80131, Naples, Italy., Staiano A; Department of Translational Medical Sciences - Section of Paediatrics, University of Naples 'Federico II', Via S. Pansini 5, 80131, Naples, Italy. staiano@unina.it., Miele E; Department of Translational Medical Sciences - Section of Paediatrics, University of Naples 'Federico II', Via S. Pansini 5, 80131, Naples, Italy. |
| Abstrakt: |
The aim of this study was to evaluate the short- and long-term outcomes of exclusive enteral nutrition (EEN) versus corticosteroids (CS) as induction therapy, in a cohort of pediatric patients with Crohn's disease (CD). A retrospective study of patients with CD has been conducted. Clinical characteristics, laboratory parameters, and pediatric Crohn's disease activity index (PCDAI) were evaluated at diagnosis and at different follow-up points. Subjects were divided in EEN-induction group, receiving EEN, and CS-induction group, treated with oral CS. We evaluated 47 patients in the EEN-induction group and 21 patients in the CS-induction group. After 8 weeks from diagnosis, we detected a significant improvement in CRP (p = 0.001) and albumin (p = 0.05), in EEN-induction group compared with the CS-induction group. PCDAI was significantly lower in the EEN-induction group versus the CS-induction group after 8 weeks (p = 0.04) and 1 year (p = 0.03) of follow-up. After 2 years from diagnosis, the number of subjects needing immunomodulators (IMM, azathioprine or methotrexate) was significantly higher in the CS-induction group compared with the EEN-induction group (p = 0.02).Conclusion: EEN has the same effectiveness of CS therapy in induction of remission but seems to have a more pronounced effect on disease activity. In our cohort, the need to use IMM seems to be reduced in subjects initially treated with EEN. What is Known: • Exclusive enteral nutrition (EEN) has the same effectiveness of corticosteroids (CS) in the induction of remission in pediatric Crohn's disease. • EEN offers numerous advantages over CS, in terms of improved nutrition and mucosal healing. What is New: • Induction of remission with EEN seems to have a more pronounced effect on disease activity compared to induction with CS. • In our cohort, induction of remission with EEN seems to reduce the need of therapy with immunomodulators at 2 years of follow-up. |
